Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 7
Submit an article Journal homepage
1,079
Views
34
CrossRef citations to date
0
Altmetric
Research Paper

Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies

Brandon S Brown Department of Neurobiology and Anatomy and Graduate School of Biomedical Sciences; The University of Texas Health Science Center at Houston; Houston, TX USA; Department of Nanomedicine; The Methodist Hospital Research Institute; Houston, TX USA
,
Tariq Patanam Department of Nanomedicine; The Methodist Hospital Research Institute; Houston, TX USA
,
Keyan Mobli Department of Neurobiology and Anatomy and Graduate School of Biomedical Sciences; The University of Texas Health Science Center at Houston; Houston, TX USA; Department of Nanomedicine; The Methodist Hospital Research Institute; Houston, TX USA
,
Christian Celia Department of Nanomedicine; The Methodist Hospital Research Institute; Houston, TX USA; Department of Pharmacy; University “G. d’Annunzio” of Chieti; Pescara, Chieti, Italy
,
Peter E Zage Dan L. Duncan Cancer Center; Baylor College of Medicine; Houston, TX USA; Section of Hematology-Oncology; Department of Pediatrics; Texas Children’s Cancer Center; Baylor College of Medicine; Houston, TX USA
,
Andrew J Bean Department of Neurobiology and Anatomy and Graduate School of Biomedical Sciences; The University of Texas Health Science Center at Houston; Houston, TX USA; Division of Pediatrics; The University of Texas M.D. Anderson Cancer Center; Houston, TX USACorrespondence[email protected]
&
Ennio Tasciotti Department of Nanomedicine; The Methodist Hospital Research Institute; Houston, TX USA
 show all
Pages 851-861 | Received 02 Feb 2014, Accepted 13 Apr 2014, Published online: 22 Apr 2014

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Wayne L Furman. (2021) Monoclonal Antibody Therapies for High Risk Neuroblastoma. Biologics: Targets and Therapy 15, pages 205-219.
Read now
Xinlong Zang, Huaiwei Ding, Xiufeng Zhao, Xiaowei Li, Zhouqi Du, Haiyang Hu, Mingxi Qiao, Dawei Chen, Yuihui Deng & Xiuli Zhao. (2016) Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA. International Journal of Nanomedicine 11, pages 3951-3967.
Read now
Maya Suzuki & Nai-Kong V Cheung. (2015) Disialoganglioside GD2 as a therapeutic target for human diseases. Expert Opinion on Therapeutic Targets 19:3, pages 349-362.
Read now

Articles from other publishers (31)

Sonia Fathi-karkan, Rabia Arshad, Abbas Rahdar, Aghdas Ramezani, Razieh Behzadmehr, Suresh Ghotekar & Sadanand Pandey. (2023) Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review. European Journal of Medicinal Chemistry 259, pages 115676.
Crossref
Miray Karamese, Necati Atalay, Senanur Kugu, Ozge Dinc, Ahmet Katı, Merve Bacanlı, Hakan Erdogan & Sevde Altuntas. (2023) FOLFIRINOX-loaded immunoliposome-like particles for localized pancreatic cancer treatment. Journal of Drug Delivery Science and Technology 86, pages 104595.
Crossref
Omowumi Akinjole, Kathryn Menta, Abdullah Alsalhi, Majid Bani-Yaghoub & Bi-Botti Celestin Youan. (2023) Novel Meta-iodobenzylguanidine and Etoposide Complex: Physicochemical Characterization and Mathematical Modeling of Anticancer Activity. AAPS PharmSciTech 24:7.
Crossref
Ana Camila Marques, Paulo C. Costa, Sérgia Velho & Maria Helena Amaral. (2023) Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 15:1, pages 216.
Crossref
M. V. DmitrievaI. V. YaroshE. V. SanarovaA. V. LantsovaO. L. Orlova. (2022) The Construction of Immunoliposomes (Review). Drug development & registration 11:3, pages 97-112.
Crossref
Xiaojing Ma, Tong Wang, Zequan Yu, Junqian Shao, Jun Chu, Huixia Zhu & Risheng Yao. (2022) Formulation and Physicochemical and Biological Characterization of Etoposide-Loaded Submicron Emulsions with Biosurfactant of Sophorolipids. AAPS PharmSciTech 23:6.
Crossref
Sarjana Raikwar & Sanjay K. Jain. 2022. Systems of Nanovesicular Drug Delivery. Systems of Nanovesicular Drug Delivery 353 365 .
Madhuchandra Kenchegowda, Mohamed Rahamathulla, Umme Hani, Mohammed Y. Begum, Sagar Guruswamy, Riyaz Ali M. Osmani, Mysore P. Gowrav, Sultan Alshehri, Mohammed M. Ghoneim, Areej Alshlowi & Devegowda V. Gowda. (2021) Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review. Molecules 27:1, pages 146.
Crossref
Gulnara Gaynanova, Leysan Vasileva, Ruslan Kashapov, Darya Kuznetsova, Rushana Kushnazarova, Anna Tyryshkina, Elmira Vasilieva, Konstantin Petrov, Lucia Zakharova & Oleg Sinyashin. (2021) Self-Assembling Drug Formulations with Tunable Permeability and Biodegradability. Molecules 26:22, pages 6786.
Crossref
Maryam Fallah, Amirhossein Davoodvandi, Shahin Nikmanzar, Sarehnaz Aghili, Seyed Mohammad Ali Mirazimi, Michael Aschner, Amir Rashidian, Michael R. Hamblin, Mohsen Chamanara, Navid Naghsh & Hamed Mirzaei. (2021) Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Biomedicine & Pharmacotherapy 142, pages 112024.
Crossref
Monica Argenziano, Silvia Arpicco, Paola Brusa, Roberta Cavalli, Daniela Chirio, Franco Dosio, Marina Gallarate, Elena Peira, Barbara Stella & Elena Ugazio. (2021) Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research. Pharmaceutics 13:10, pages 1538.
Crossref
Ying Xu, Lei Tang, Yulong Liu, Chen Qian, Peng Chen, Yuanrong Xin, Hongfei Liu & Yang Qu. (2021) Dual-modified albumin-polymer nanocomplexes with enhanced in vivo stability for hepatocellular carcinoma therapy. Colloids and Surfaces B: Biointerfaces 201, pages 111642.
Crossref
Taranom Mobasheri, Elham Rayzan, Mahsima Shabani, Mina Hosseini, Ghanbar Mahmoodi Chalbatani & Nima Rezaei. (2020) Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods. Journal of Cellular Physiology 236:3, pages 1751-1775.
Crossref
Mural Quadros, Munira Momin & Gunjan Verma. (2021) Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma. Materials Science and Engineering: C 121, pages 111875.
Crossref
Jeong A. Park & Nai-Kong V. Cheung. (2020) Targets and Antibody Formats for Immunotherapy of Neuroblastoma. Journal of Clinical Oncology 38:16, pages 1836-1848.
Crossref
Shigeru Kawakami & Tadaharu Suga. (2020) Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging多色深部イメージングを利用した空間分布制御型ナノDDSの開発. YAKUGAKU ZASSHI 140:5, pages 633-640.
Crossref
Shivani Saraf, Ankit Jain, Ankita Tiwari, Amit Verma, Pritish Kumar Panda & Sanjay K. Jain. (2020) Advances in liposomal drug delivery to cancer: An overview. Journal of Drug Delivery Science and Technology 56, pages 101549.
Crossref
Ali Dehshahri, Milad Ashrafizadeh, Elham Ghasemipour Afshar, Abbas Pardakhty, Ali Mandegary, Reza Mohammadinejad & Gautam Sethi. (2020) Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems. Pharmacological Research 151, pages 104551.
Crossref
Hira Choudhury, Rahul Maheshwari, Manisha Pandey, Muktika Tekade, Bapi Gorain & Rakesh Kumar Tekade. (2020) Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide’. Materials Science and Engineering: C 106, pages 110275.
Crossref
Fahimeh Zahednezhad, Maryam Saadat, Hadi Valizadeh, Parvin Zakeri-Milani & Behzad Baradaran. (2019) Liposome and immune system interplay: Challenges and potentials. Journal of Controlled Release 305, pages 194-209.
Crossref
Roman V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Eugene D. Ponomarev & Irina V. Kholodenko. (2019) Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations. Current Medicinal Chemistry 26:3, pages 396-426.
Crossref
Burcin Yavuz, Jasmine Zeki, Jeannine M. Coburn, Naohiko Ikegaki, Daniel Levitin, David L. Kaplan & Bill Chiu. (2018) In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment. Journal of Controlled Release 285, pages 162-171.
Crossref
Irina V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Sergey M. Deyev & Roman V. Kholodenko. (2018) Neuroblastoma Origin and Therapeutic Targets for Immunotherapy. Journal of Immunology Research 2018, pages 1-25.
Crossref
Maryam Mombeini, Ghasem Saki, Layasadat Khorsandi & Neda Bavarsad. (2018) Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells. Medicina 54:1, pages 1.
Crossref
Sharareh Gholamin, Hamed Mirzaei, Seyed‐Mostafa Razavi, Seyed Mahdi Hassanian, Leila Saadatpour, Aria Masoudifar, Soodabeh ShahidSales & Amir Avan. (2017) GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma. Journal of Cellular Physiology 233:2, pages 866-879.
Crossref
Roger Gilabert-Oriol, Lina Chernov, Rebecca J. Deyell & Marcel B. Bally. 2018. Lipid Nanocarriers for Drug Targeting. Lipid Nanocarriers for Drug Targeting 361 411 .
A. A. Zubareva, A. A. Boyko, I. V. Kholodenko, F. N. Rozov, M. V. Larina, T. K. Aliev, I. I. Doronin, P. A. Vishnyakova, I. M. Molotkovskaya & R. V. Kholodenko. (2016) Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2. Russian Journal of Bioorganic Chemistry 42:5, pages 532-545.
Crossref
Yue Cheng, Wenbo Xu, Zhen Chen, Zhixiang Wang & Dechun Huang. (2016) Micronization of etoposide using solution-enhanced dispersion by supercritical CO2. The Journal of Supercritical Fluids 115, pages 10-16.
Crossref
Thomas Carter, Paul Mulholland & Kerry Chester. (2016) Antibody-targeted nanoparticles for cancer treatment. Immunotherapy 8:8, pages 941-958.
Crossref
Shyamasree Ghosh & Waliza Ansar. 2015. Nanoparticles' Promises and Risks. Nanoparticles' Promises and Risks 167 210 .
Huei Ng, Aiping Lu, Ge Lin, Ling Qin & Zhijun Yang. (2014) The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo. International Journal of Molecular Sciences 16:1, pages 230-255.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.